Eintrag weiter verarbeiten
Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer
Gespeichert in:
Zeitschriftentitel: | Cancer Epidemiology, Biomarkers & Prevention |
---|---|
Personen und Körperschaften: | , , , , , , |
In: | Cancer Epidemiology, Biomarkers & Prevention, 16, 2007, 1, S. 165-168 |
Format: | E-Article |
Sprache: | Englisch |
veröffentlicht: |
American Association for Cancer Research (AACR)
|
Schlagwörter: |
author_facet |
Berndt, Sonja I. Chatterjee, Nilanjan Huang, Wen-Yi Chanock, Stephen J. Welch, Robert Crawford, E. David Hayes, Richard B. Berndt, Sonja I. Chatterjee, Nilanjan Huang, Wen-Yi Chanock, Stephen J. Welch, Robert Crawford, E. David Hayes, Richard B. |
---|---|
author |
Berndt, Sonja I. Chatterjee, Nilanjan Huang, Wen-Yi Chanock, Stephen J. Welch, Robert Crawford, E. David Hayes, Richard B. |
spellingShingle |
Berndt, Sonja I. Chatterjee, Nilanjan Huang, Wen-Yi Chanock, Stephen J. Welch, Robert Crawford, E. David Hayes, Richard B. Cancer Epidemiology, Biomarkers & Prevention Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer Oncology Epidemiology |
author_sort |
berndt, sonja i. |
spelling |
Berndt, Sonja I. Chatterjee, Nilanjan Huang, Wen-Yi Chanock, Stephen J. Welch, Robert Crawford, E. David Hayes, Richard B. 1055-9965 1538-7755 American Association for Cancer Research (AACR) Oncology Epidemiology http://dx.doi.org/10.1158/1055-9965.epi-06-0689 <jats:title>Abstract</jats:title> <jats:p>Sex hormones have been implicated in prostate carcinogenesis and are thought to modulate cell proliferation and growth. To investigate the association between polymorphisms in hormone-related genes and prostate cancer risk, we conducted a two-stage, case-control study within the screening arm of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Using DNA extracted from blood specimens, we initially genotyped 14 single nucleotide polymorphisms in genes involved in hormone regulation or metabolism (AKR1C3, CYP1A1, CYP1B1, CYP3A4, ESR1, GNRH1, HSD173B, HSD3B2, SHBG, and SRD5A2) in 488 prostate cancer cases and 617 matched controls. Heterozygotes at SHBG D356N were found to be associated with an increased risk of prostate cancer compared with the homozygous wild type, particularly among non-Hispanic whites (odds ratio, 1.54; 95% confidence interval, 1.13-2.09; P = 0.006). No significant associations were observed with the other polymorphisms. The SHBG D356N polymorphism, which has potential functional significance, was subsequently genotyped in additional 769 cases and 1,168 controls. Overall, SHBG D356N heterozygotes were found to have an increased risk of prostate cancer among whites (odds ratio, 1.34; 95% confidence interval, 1.10-1.63; P = 0.0007). This study suggests that genetic variation in SHBG may influence prostate cancer susceptibility. (Cancer Epidemiol Biomarkers Prev 2007;16(1):165–8)</jats:p> Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer Cancer Epidemiology, Biomarkers & Prevention |
doi_str_mv |
10.1158/1055-9965.epi-06-0689 |
facet_avail |
Online Free |
finc_class_facet |
Medizin |
format |
ElectronicArticle |
fullrecord |
blob:ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDU1LTk5NjUuZXBpLTA2LTA2ODk |
id |
ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDU1LTk5NjUuZXBpLTA2LTA2ODk |
institution |
DE-Zwi2 DE-D161 DE-Gla1 DE-Zi4 DE-15 DE-Pl11 DE-Rs1 DE-105 DE-14 DE-Ch1 DE-L229 DE-D275 DE-Bn3 DE-Brt1 |
imprint |
American Association for Cancer Research (AACR), 2007 |
imprint_str_mv |
American Association for Cancer Research (AACR), 2007 |
issn |
1055-9965 1538-7755 |
issn_str_mv |
1055-9965 1538-7755 |
language |
English |
mega_collection |
American Association for Cancer Research (AACR) (CrossRef) |
match_str |
berndt2007variantinsexhormonebindingglobulingeneandtheriskofprostatecancer |
publishDateSort |
2007 |
publisher |
American Association for Cancer Research (AACR) |
recordtype |
ai |
record_format |
ai |
series |
Cancer Epidemiology, Biomarkers & Prevention |
source_id |
49 |
title |
Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer |
title_unstemmed |
Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer |
title_full |
Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer |
title_fullStr |
Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer |
title_full_unstemmed |
Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer |
title_short |
Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer |
title_sort |
variant in sex hormone-binding globulin gene and the risk of prostate cancer |
topic |
Oncology Epidemiology |
url |
http://dx.doi.org/10.1158/1055-9965.epi-06-0689 |
publishDate |
2007 |
physical |
165-168 |
description |
<jats:title>Abstract</jats:title>
<jats:p>Sex hormones have been implicated in prostate carcinogenesis and are thought to modulate cell proliferation and growth. To investigate the association between polymorphisms in hormone-related genes and prostate cancer risk, we conducted a two-stage, case-control study within the screening arm of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Using DNA extracted from blood specimens, we initially genotyped 14 single nucleotide polymorphisms in genes involved in hormone regulation or metabolism (AKR1C3, CYP1A1, CYP1B1, CYP3A4, ESR1, GNRH1, HSD173B, HSD3B2, SHBG, and SRD5A2) in 488 prostate cancer cases and 617 matched controls. Heterozygotes at SHBG D356N were found to be associated with an increased risk of prostate cancer compared with the homozygous wild type, particularly among non-Hispanic whites (odds ratio, 1.54; 95% confidence interval, 1.13-2.09; P = 0.006). No significant associations were observed with the other polymorphisms. The SHBG D356N polymorphism, which has potential functional significance, was subsequently genotyped in additional 769 cases and 1,168 controls. Overall, SHBG D356N heterozygotes were found to have an increased risk of prostate cancer among whites (odds ratio, 1.34; 95% confidence interval, 1.10-1.63; P = 0.0007). This study suggests that genetic variation in SHBG may influence prostate cancer susceptibility. (Cancer Epidemiol Biomarkers Prev 2007;16(1):165–8)</jats:p> |
container_issue |
1 |
container_start_page |
165 |
container_title |
Cancer Epidemiology, Biomarkers & Prevention |
container_volume |
16 |
format_de105 |
Article, E-Article |
format_de14 |
Article, E-Article |
format_de15 |
Article, E-Article |
format_de520 |
Article, E-Article |
format_de540 |
Article, E-Article |
format_dech1 |
Article, E-Article |
format_ded117 |
Article, E-Article |
format_degla1 |
E-Article |
format_del152 |
Buch |
format_del189 |
Article, E-Article |
format_dezi4 |
Article |
format_dezwi2 |
Article, E-Article |
format_finc |
Article, E-Article |
format_nrw |
Article, E-Article |
_version_ |
1792339325526999055 |
geogr_code |
not assigned |
last_indexed |
2024-03-01T15:45:53.268Z |
geogr_code_person |
not assigned |
openURL |
url_ver=Z39.88-2004&ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fvufind.svn.sourceforge.net%3Agenerator&rft.title=Variant+in+Sex+Hormone-Binding+Globulin+Gene+and+the+Risk+of+Prostate+Cancer&rft.date=2007-01-01&genre=article&issn=1538-7755&volume=16&issue=1&spage=165&epage=168&pages=165-168&jtitle=Cancer+Epidemiology%2C+Biomarkers+%26+Prevention&atitle=Variant+in+Sex+Hormone-Binding+Globulin+Gene+and+the+Risk+of+Prostate+Cancer&aulast=Hayes&aufirst=Richard+B.&rft_id=info%3Adoi%2F10.1158%2F1055-9965.epi-06-0689&rft.language%5B0%5D=eng |
SOLR | |
_version_ | 1792339325526999055 |
author | Berndt, Sonja I., Chatterjee, Nilanjan, Huang, Wen-Yi, Chanock, Stephen J., Welch, Robert, Crawford, E. David, Hayes, Richard B. |
author_facet | Berndt, Sonja I., Chatterjee, Nilanjan, Huang, Wen-Yi, Chanock, Stephen J., Welch, Robert, Crawford, E. David, Hayes, Richard B., Berndt, Sonja I., Chatterjee, Nilanjan, Huang, Wen-Yi, Chanock, Stephen J., Welch, Robert, Crawford, E. David, Hayes, Richard B. |
author_sort | berndt, sonja i. |
container_issue | 1 |
container_start_page | 165 |
container_title | Cancer Epidemiology, Biomarkers & Prevention |
container_volume | 16 |
description | <jats:title>Abstract</jats:title> <jats:p>Sex hormones have been implicated in prostate carcinogenesis and are thought to modulate cell proliferation and growth. To investigate the association between polymorphisms in hormone-related genes and prostate cancer risk, we conducted a two-stage, case-control study within the screening arm of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Using DNA extracted from blood specimens, we initially genotyped 14 single nucleotide polymorphisms in genes involved in hormone regulation or metabolism (AKR1C3, CYP1A1, CYP1B1, CYP3A4, ESR1, GNRH1, HSD173B, HSD3B2, SHBG, and SRD5A2) in 488 prostate cancer cases and 617 matched controls. Heterozygotes at SHBG D356N were found to be associated with an increased risk of prostate cancer compared with the homozygous wild type, particularly among non-Hispanic whites (odds ratio, 1.54; 95% confidence interval, 1.13-2.09; P = 0.006). No significant associations were observed with the other polymorphisms. The SHBG D356N polymorphism, which has potential functional significance, was subsequently genotyped in additional 769 cases and 1,168 controls. Overall, SHBG D356N heterozygotes were found to have an increased risk of prostate cancer among whites (odds ratio, 1.34; 95% confidence interval, 1.10-1.63; P = 0.0007). This study suggests that genetic variation in SHBG may influence prostate cancer susceptibility. (Cancer Epidemiol Biomarkers Prev 2007;16(1):165–8)</jats:p> |
doi_str_mv | 10.1158/1055-9965.epi-06-0689 |
facet_avail | Online, Free |
finc_class_facet | Medizin |
format | ElectronicArticle |
format_de105 | Article, E-Article |
format_de14 | Article, E-Article |
format_de15 | Article, E-Article |
format_de520 | Article, E-Article |
format_de540 | Article, E-Article |
format_dech1 | Article, E-Article |
format_ded117 | Article, E-Article |
format_degla1 | E-Article |
format_del152 | Buch |
format_del189 | Article, E-Article |
format_dezi4 | Article |
format_dezwi2 | Article, E-Article |
format_finc | Article, E-Article |
format_nrw | Article, E-Article |
geogr_code | not assigned |
geogr_code_person | not assigned |
id | ai-49-aHR0cDovL2R4LmRvaS5vcmcvMTAuMTE1OC8xMDU1LTk5NjUuZXBpLTA2LTA2ODk |
imprint | American Association for Cancer Research (AACR), 2007 |
imprint_str_mv | American Association for Cancer Research (AACR), 2007 |
institution | DE-Zwi2, DE-D161, DE-Gla1, DE-Zi4, DE-15, DE-Pl11, DE-Rs1, DE-105, DE-14, DE-Ch1, DE-L229, DE-D275, DE-Bn3, DE-Brt1 |
issn | 1055-9965, 1538-7755 |
issn_str_mv | 1055-9965, 1538-7755 |
language | English |
last_indexed | 2024-03-01T15:45:53.268Z |
match_str | berndt2007variantinsexhormonebindingglobulingeneandtheriskofprostatecancer |
mega_collection | American Association for Cancer Research (AACR) (CrossRef) |
physical | 165-168 |
publishDate | 2007 |
publishDateSort | 2007 |
publisher | American Association for Cancer Research (AACR) |
record_format | ai |
recordtype | ai |
series | Cancer Epidemiology, Biomarkers & Prevention |
source_id | 49 |
spelling | Berndt, Sonja I. Chatterjee, Nilanjan Huang, Wen-Yi Chanock, Stephen J. Welch, Robert Crawford, E. David Hayes, Richard B. 1055-9965 1538-7755 American Association for Cancer Research (AACR) Oncology Epidemiology http://dx.doi.org/10.1158/1055-9965.epi-06-0689 <jats:title>Abstract</jats:title> <jats:p>Sex hormones have been implicated in prostate carcinogenesis and are thought to modulate cell proliferation and growth. To investigate the association between polymorphisms in hormone-related genes and prostate cancer risk, we conducted a two-stage, case-control study within the screening arm of the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial. Using DNA extracted from blood specimens, we initially genotyped 14 single nucleotide polymorphisms in genes involved in hormone regulation or metabolism (AKR1C3, CYP1A1, CYP1B1, CYP3A4, ESR1, GNRH1, HSD173B, HSD3B2, SHBG, and SRD5A2) in 488 prostate cancer cases and 617 matched controls. Heterozygotes at SHBG D356N were found to be associated with an increased risk of prostate cancer compared with the homozygous wild type, particularly among non-Hispanic whites (odds ratio, 1.54; 95% confidence interval, 1.13-2.09; P = 0.006). No significant associations were observed with the other polymorphisms. The SHBG D356N polymorphism, which has potential functional significance, was subsequently genotyped in additional 769 cases and 1,168 controls. Overall, SHBG D356N heterozygotes were found to have an increased risk of prostate cancer among whites (odds ratio, 1.34; 95% confidence interval, 1.10-1.63; P = 0.0007). This study suggests that genetic variation in SHBG may influence prostate cancer susceptibility. (Cancer Epidemiol Biomarkers Prev 2007;16(1):165–8)</jats:p> Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer Cancer Epidemiology, Biomarkers & Prevention |
spellingShingle | Berndt, Sonja I., Chatterjee, Nilanjan, Huang, Wen-Yi, Chanock, Stephen J., Welch, Robert, Crawford, E. David, Hayes, Richard B., Cancer Epidemiology, Biomarkers & Prevention, Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer, Oncology, Epidemiology |
title | Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer |
title_full | Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer |
title_fullStr | Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer |
title_full_unstemmed | Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer |
title_short | Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer |
title_sort | variant in sex hormone-binding globulin gene and the risk of prostate cancer |
title_unstemmed | Variant in Sex Hormone-Binding Globulin Gene and the Risk of Prostate Cancer |
topic | Oncology, Epidemiology |
url | http://dx.doi.org/10.1158/1055-9965.epi-06-0689 |